CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.

ITW gains from strength in its businesses, enterprise initiatives and shareholder-friendly moves. Softness in semiconductor-related business persists.

AXON benefits from strength across its businesses, product introductions and complementary acquisitions. Rising costs and expenses may hurt its...

CSL benefits from strength across its business, acquisitions and shareholder-friendly policies. Rising costs and expenses may hurt its profitability.

Innovations and a robust diabetes market outlook raise investors' optimism for TNDM.

JCI is set to benefit from strength in its Building Solutions North America segment. However, persistent weakness in system sales in China remains a...

JCI is set to benefit from strength in its Building Solutions North America segment. However, persistent weakness in system sales in China remains a...

TDY makes a strong case for investment in the aerospace sector, given its long-run growth prospects, low debt and strategic acquisitions.

SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.

Abbott's robust strength in Core Diagnostics and EPD businesses should continue to benefit in the upcoming quarters.